Novel Elbow Splint Commences Clinical Trials in Patients with Ulnar Neuropathies

09:48 EDT 19 Oct 2016 | Zyme Communications

Health Enterprise East supported project recruits first patients in trial at Addenbrooke’s Hospital, Cambridge

Cambridge, UK, 19 October 2016 – Health Enterprise East (HEE), a leading NHS innovation hub, has announced that it is to commence clinical trials at Cambridge University Hospitals NHS Foundation Trust, a world renowned centre of healthcare innovation, of the Cambridge Ulnar Splint for treatment of patients suffering neuropathies at the elbow. This common condition, sometimes known as Cubital Tunnel Syndrome, is caused by nerve entrapment that often results in numbness of the little and ring fingers, and sometimes considerable pain and disability for patients. It is particularly prevalent in jobs such as manual labour and office work where repetitive tasks with protracted periods of elbow flexion are involved.

The splint has been developed by Dr Andy Michell, a consultant in Clinical Neurophysiology at Cambridge University Hospitals NHS Foundation Trust, with support from HEE and Cambridge University Hospitals NHS Foundation Trust. The device won a HEE Innovation Award in 2015, with the funds used to prepare for clinical evaluation through early stage prototyping and device manufacture. Results of the clinical trial are due to be announced in early 2017.

The Cambridge Ulnar Splint is a first line, early intervention treatment that, once developed, will be available to patients over the counter. It provides a flexible exoskeleton to help alleviate direct pressure on the trapped nerve, and stops the nerve irritation that causes symptoms such as pain, numbness and tingling in the fingers. The device also has a simple mechanism whereby flexion of the elbow can be restricted as and when required, making it adaptable and particularly patient-friendly.

James Clulow, Technology Associate at HEE said: “This is a great example of HEE working collaboratively with innovative individuals within the NHS to develop their ideas and help transition, in this instance, from an initial concept through prototype development, to a device that is ready for clinical trials. We eagerly await the trial results and look forward to seeing the splint commercially available and making a real impact with patients.”

Dr Andy Michell added: “This is a significant milestone in the development of the Cambridge Ulnar Splint and we look forward to the trial results. This is the first splint specifically design to protect the nerve at the elbow, unlike the braces and splints currently available to patients. We anticipate it being used like the carpal tunnel splints which are popular worldwide – the Cambridge Ulnar Splint could be purchased directly by patients, or provided in primary care. We are seeking commercial partners to help us take the splint to market.”
For more information on HEE supported projects visit

Dr Andy Michell

About Health Enterprise East

Health Enterprise East (HEE) is a leading NHS innovation hub committed to improving healthcare through the provision of professional business and innovation management services. The HEE team works with NHS organisations nationally and Med Tech companies globally to support the development of innovative products and services which meet currently unmet healthcare needs. The company offers a broad range of tailored services from strategic analysis and market validation, to practical advice and insight.
Through its member services, HEE also ensures that pioneering innovations from staff across the NHS are identified, developed and commercialised for the benefit of patients, staff and society. Closely affiliated with founding member Papworth Hospital NHS Foundation Trust, HEE currently serves over 30 NHS organisations in the East of England, East Midlands and North London. Trusts can opt to sign up as members of HEE and access a full range of skills and expertise.

Zyme Communications Sarah Jeffery E-mail: Phone: +44 (0) 7771 730919 Health Enterprise East Chris Armstrong Email: Phone: +44 (0)1223 928040 NEXT ARTICLE

More From BioPortfolio on "Novel Elbow Splint Commences Clinical Trials in Patients with Ulnar Neuropathies"

Quick Search

Relevant Topics

Clinical Approvals
Clinical trials are a set of procedures in medical research conducted to allow safety (or more specifically, information about adverse drug reactions and adverse effects of other treatments) and efficacy data to be collected for health interventions (e.g...

Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...

Joint Disorders
A joint is where two or more bones come together, like the knee, hip, elbow, or shoulder. Joints can be damaged by many types of injuries or diseases, including Arthritis - inflammation of a joint causes pain, stiffness, and swelling with ...